MR vs CT imaging: Low rectal cancer tumour delineation for three-dimensional conformal radiotherapy

British Journal of Radiology

Volumn 82, Issue 978, 2009, Pages 509-513

  O'Neill, Brian D P ^a,c,d   Salerno, G ^b   Thomas, K ^a   Tait, D M ^a   Brown, G ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^c ST LUKE S HOSPITAL   (Ireland)

^d BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANUS SPHINCTER; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; RECTUM CANCER; THREE DIMENSIONAL COMPUTER ASSISTED RADIOTHERAPY; TUMOR VOLUME;

FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PRONE POSITION; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTAL NEOPLASMS; SUPINE POSITION; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 66749116170     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/60198873     Document Type: Article

References (17)

1. Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients - a Dutch colorectal cancer group study. J Clin Oncol 2005;23:6199-6206
2. Pollack J, Holm T, Cedermark B, Holmstrom B, Mellgren A. Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rect 2006;49:345-352
3. Fokdal L, Honore H, Hoyer M, von der Maase H. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol 2005;74:203-210
4. al-Abany M, Helgason AR, Cronqvist AK, Lind B, Mavroidis P, Wersall P, et al. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys 2005;61:1035-1044
5. Mangar SA, Sydes MR, Tucker HL, Coffey J, Sohaib SA, Gianolini S, et al. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397). Radiother Oncol 2006;80:355-362
6. Dearnaley DP, Sydes MR, Langley RE, Graham JD, Huddart RA, Syndikus I, et al. The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397). Radiother Oncol 2007;83:31-41.
7. Blomqvist L, Rubio C, Holm T, Machado M, Hindmarsh T. Rectal adenocarcinoma: assessment of tumour involvement of the lateral resection margin by MRI of resected specimen. Br J Radiol 1999;72:18-23.
8. Brown G, Richards CJ, Newcombe RG, Dallimore NS, Radcliffe AG, Carey DP, et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999;211:215-222
9. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003;90:355-364
10. MERCURY. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br Med J 2006;333:779.
11. Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006;24:668-674
12. Rajasekar D, Datta NR, Gupta RK, Pradhan PK, Ayyagari S. Multimodality image fusion in dose escalation studies of brain tumors. J Appl Clin Med Phys 2003;4:8-16.
13. Gerard JP, Chapet O, Nemoz C, Hartweig J, Romestaing P, Coquard R, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial. J Clin Oncol 2004;22:2404-2409
14. Mohiuddin M, Regine WF, John WJ, Hagihara PF, McGrath PC, Kenady DE, et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000;46:883-888
15. Mohiuddin M, Winter K, Mitchell E, Hanna N, Yuen A, Nichols C, et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 2006;24:650-655
16. O'Neill BD, Brown G, Heald RJ, Cunningham D, Tait DM. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007;8:625-633
17. Tait DM, Drzymala M, Henrys AJ, Norman A, Hawkins M, Bedford J. To determine the volume of bowel and dose received in the pelvic radiation field for rectal cancer in the prone and supine position. ASTRO annual meeting; 2005 October 16-20; Denver, CO. Abstract 1035.